Amplifon, IT0004056880

Amplifon stock trades at EUR 12.79 on 32.32 percent of average volume

Published on 10/12/2026 at 13:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Amplifon stock is 0.54 percent below the Xetra close of October 9, 2026. Lang & Schwarz quoted EUR 12.79 on October 12, 2026.

Key points in brief

  • Amplifon stock was at EUR 12.79 at Lang & Schwarz on October 12, 2026 at 1:17 p.m. CEST.
  • The price stood 0.54 percent below the Xetra close of October 9, 2026, at EUR 12.86.
  • Amplifon's market capitalization was EUR 2.8 billion and its P/E ratio was 42.31.
  • Morgan Stanley raised its Amplifon target to EUR 14.96 from EUR 14.90 on October 9, 2026.
Dokumentarische Schwarzweißaufnahme einer Hörgeräte-Anpassung beim Facharzt
Schwarzweiß-Reportagefoto dokumentiert eine authentische Hörtest-Szene, thematisch verbunden mit Amplifon S.p.A., ISIN IT0004056880, Gesundheitssektor, Illustration mit AI erstellt.

Amplifon stock was trading at EUR 12.79 at Lang & Schwarz on October 12, 2026 at 1:17 p.m. CEST, down 0.54 percent versus the Xetra close of October 9, 2026 at EUR 12.86. The current quote places the hearing-solutions group below its latest Xetra reference while the market tracks volume, valuation and the next reporting date.

Volume trails the average

Trading volume stood at 495,328 shares at the quoted time, compared with an average volume of 1,532,474 shares. That equals 32.32 percent of the average, making participation the clearest short-term market signal in the available quote.

The bid was EUR 12.78 and the ask was EUR 12.80. Amplifon's 52-week range was EUR 7.84 to EUR 15.84, placing the Lang & Schwarz price 19.26 percent below the high and 63.01 percent above the low.

Valuation stays in focus

Amplifon's market capitalization was EUR 2.8 billion and its P/E ratio was 42.31 on October 12, 2026. The valuation is therefore being assessed against both the company's operating recovery and the execution demands surrounding its planned GN Hearing transaction.

Repubblica reported on October 9, 2026 that Morgan Stanley kept its Overweight recommendation and raised the target to EUR 14.96 from EUR 14.90. The new target lies 16.97 percent above the Lang & Schwarz price.

OraFinanza reported on October 5, 2026 that AlphaValue lifted its target from EUR 13.20 to EUR 16.70 and upgraded its view from Add to Buy. The target change creates a 26.52 percent increase from the former level.

Comparison with peers

Amplifon (Lang & Schwarz, EUR): minus 0.54 percent, P/E 42.31, market capitalization EUR 2.8 billion
Demant (Nasdaq Copenhagen, DKK): plus 2.34 percent, P/E 45.29, market capitalization DKK 73.6 billion
FTSE MIB: , ,

Next date is October 29

Amplifon scheduled its shareholder meeting for October 29, 2026, while the third-quarter and nine-month results are also expected on that date. The first-half 2026 figures reported revenue of EUR 1.19 billion, up 1.30 percent at constant exchange rates, according to Rankia.

Price remains below the high

Amplifon was trading at EUR 12.79 at Lang & Schwarz on October 12, 2026 at 1:17 p.m. CEST, or minus 0.54 percent versus the Xetra close of October 9, 2026 at EUR 12.86. The price was 19.26 percent below the 52-week high of EUR 15.84.
The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.

Amplifon stock facts

  • Company: Amplifon S.p.A.
  • ISIN: IT0004056880
  • Ticker: AMP
  • Primary exchange: Euronext Milan
  • Price Lang & Schwarz (as of October 12, 2026, 1:17 p.m. CEST): EUR 12.79
  • Change versus Xetra close: minus 0.54 percent
  • Xetra close (October 9, 2026): EUR 12.86
  • Market capitalization: EUR 2.8 billion (as of October 12, 2026)
  • 52-week range: EUR 7.84-EUR 15.84 (as of October 12, 2026)
  • Sector / Industry: Health Care / Hearing solutions
  • Index membership: FTSE MIB

Market context: Market report FTSE MIB.

More news and analyses on Amplifon stock

Disclaimer...

en | IT0004056880 | AMPLIFON | boerse | 70301238 | bgmi